Equities

Terrascend Corp

Terrascend Corp

Actions
  • Price (EUR)1.60
  • Today's Change-0.12 / -6.98%
  • Shares traded1.50k
  • 1 Year change+9.22%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

TerrAscend Corp. is a Canada-based cannabis company. The Company provides cannabis products, brands, and services to the United States and Canadian cannabinoid markets. It operates in Pennsylvania, New Jersey, Maryland, Michigan and California through TerrAscend Growth Corp. (TerrAscend Growth) and retail operations in Canada. The Company operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. It also operates Peninsula Alternative Health, a medical dispensary in Maryland. The Company owns or licenses several synergistic businesses and brands, including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, and Valhalla Confections. Ilera Healthcare is a medical cannabis cultivator, processor and dispenser with operations in New Jersey. Valhalla Confections is a manufacturer of cannabis-infused edibles.

  • Revenue in CAD (TTM)447.14m
  • Net income in CAD-118.12m
  • Incorporated2017
  • Employees742.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
TSND:TOR since
announced
Transaction
value
Herbiculture IncDeal completed30 Jun 202330 Jun 2023Deal completed2.93%8.25m
Hempaid LLCAnnounced27 Jun 202327 Jun 2023Announced13.89%6.75m
Derby 1 LLCDeal completed08 Jun 202308 Jun 2023Deal completed13.89%22.10m
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.